Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
The Oncologist|June 29, 2026
Dose-Expansion Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid TumorsApostolia Maria Tsimberidou, Darren Sigal, Anna Varghese, et al.
British Journal of Cancer|March 6, 2021
Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignanciesShuyang Yao, Filip Janku, Vivek Subbiah, et al.
Cell Transplantation|February 26, 2021
Feasibility of Umbilical Cord Blood Collection in Neonates at Risk of Brain Damage-A Step Toward Autologous Cell Therapy for a High-risk PopulationAngela Segler, Thorsten Braun, Hendrik Stefan Fischer, et al.
Journal of Surgical Oncology|February 16, 2018
Neutrophil: Lymphocyte ratio as a method of predicting complications following hepatic resection for colorectal liver metastasisSimon J McCluney, Alexandros Giakoustidis, Angela Segler, et al.
Oncotarget|October 15, 2014
Outcomes of patients with advanced cancer and KRAS mutations in phase I clinical trialsRabih Said, Yang Ye, Gerald Steven Falchook, et al.
Leukemia|November 16, 2021
Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9Friederike Christen, Raphael Hablesreiter, Kaja Hoyer, et al.
NPJ Precision Oncology|April 10, 2026
Outcomes of patients with or without DNA repair pathway alterations: the MD Anderson IMPACT2 studyJacopo Venturini, Mehmet A Baysal, Abhijit Chakraborty, et al.
Cancer Chemotherapy and Pharmacology|June 14, 2023
A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutationSarina A Piha-Paul, Chieh Tseng, Hai T Tran, et al.
NPJ Precision Oncology|January 13, 2026
Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD AndersonJeong Uk Lim, Heather Y Lin, Lei Kang, et al.
ANZ Journal of Surgery|July 18, 2018
Predicting complications in hepatic resection for colorectal liver metastasis: the lymphocyte-to-monocyte ratioSimon J McCluney, Alexandros A Giakoustidis, Angela Segler, et al.
Pageof 11